Trials of Hormonal Contraceptive Drugs Get New FDA Guidance

Drug Industry Daily
A A
The FDA issued a draft guidance for trials of hormonal birth control products that makes recommendations regarding enrollment criteria, study elements, and safety and efficacy considerations.

To View This Article:

Login

Subscribe To Drug Industry Daily